Back to Search
Start Over
Incomplete echocardiographic recovery at 6months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial
- Source :
- Clinical Research in Cardiology, 108(7), 772-778. SPRINGER HEIDELBERG, Clinical Research in Cardiology
- Publication Year :
- 2019
-
Abstract
- INTRODUCTION: Symptoms and functional limitation are frequently reported by survivors of acute pulmonary embolism (PE). However, current guidelines provide no specific recommendations on which patients should be followed after acute PE, when follow-up should be performed, and which tests it should include. Definition and classification of late PE sequelae are evolving, and their predictors remain to be determined. METHODS: In a post hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial, we focused on 219 survivors of acute intermediate-risk PE with clinical and echocardiographic follow-up 6 months after randomisation as well as over the long term (median, 3 years after acute PE). The primary outcome was a composite of (1) confirmed chronic thromboembolic pulmonary hypertension (CTEPH) or (2) 'post-PE impairment' (PPEI), defined by echocardiographic findings indicating an intermediate or high probability of pulmonary hypertension along with New York Heart Association functional class II-IV. RESULTS: Confirmed CTEPH or PPEI occurred in 29 (13.2%) patients, (6 with CTEPH and 23 with PPEI). A history of chronic heart failure at baseline and incomplete or absent recovery of echocardiographic parameters at 6 months predicted CTEPH or PPEI at long-term follow-up. CONCLUSIONS: CTEPH or PPEI occurs in almost one out of seven patients after acute intermediate-risk PE. Six-month echocardiographic follow-up may be useful for timely detection of late sequelae. peerReviewed
- Subjects :
- Male
Time Factors
medicine.medical_treatment
Chronic thromboembolic pulmonary hypertension
Post-PE impairment
Pulmonary embolism
Right ventricular dysfunction
Risk stratification
Acute Disease
Disease Progression
Echocardiography
Female
Fibrinolytic Agents
Follow-Up Studies
Heart Ventricles
Humans
Middle Aged
Pulmonary Embolism
Retrospective Studies
Risk Factors
Tenecteplase
Thrombolytic Therapy
Treatment Outcome
Ventricular Function, Right
Recovery of Function
030204 cardiovascular system & hematology
New york heart association
0302 clinical medicine
Ventricular Function
030212 general & internal medicine
General Medicine
Thrombolysis
3. Good health
ddc
Right
Cardiology
Cardiology and Cardiovascular Medicine
medicine.medical_specialty
03 medical and health sciences
Internal medicine
Post-hoc analysis
medicine
Original Paper
business.industry
medicine.disease
Pulmonary hypertension
Heart failure
business
Intermediate risk
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Clinical Research in Cardiology, 108(7), 772-778. SPRINGER HEIDELBERG, Clinical Research in Cardiology
- Accession number :
- edsair.doi.dedup.....cc6ff63c20d08f424547237227d9f54a